Funding awarded
- The Role of NAD+ Metabolism in Obesity-Induced Pancreatic Beta-Cell Dysfunction awarded by National Institute of Diabetes & Digestive & Kidney Diseases Co-Investigator 2025 - 2030
- Mechanisms of Obesity-induced Atrial Fibrillation awarded by National Heart, Lung, & Blood Institute Co-Investigator 2025 - 2028
- Targeting GDF15-GFRAL signaling in mitochondrial myopathies awarded by National Inst of Arthritis & Musculoskeletal & Skin Diseases Co-Investigator 2025 - 2027
- Pre-malignant mutation landscape and risk factors for progression to hematologic cancers awarded by National Cancer Institute Co-Investigator 2021 - 2027
- Mechanisms Of Camp-Dependent Regulation Of Melanosome Ph awarded by National Inst of Arthritis & Musculoskeletal & Skin Diseases Co-Investigator 2021 - 2026
- Metabolic landscape and mitochondrial ROS balance in brain ischemia/reperfusion awarded by National Institute of Neurological Disorders & Stroke Co-Principal Investigator 2024 - 2028
- Metabolic remodeling of skeletal muscle in mitochondrial myopathies awarded by National Inst of Arthritis & Musculoskeletal & Skin Diseases Co-Principal Investigator 2020 - 2026
- "Intervention Strategies for Non-Folate Responsive Neural Tube Defects" awarded by National Institute of Child Health & Human Development Key Personnel 2021 - 2026